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INTRODUCTION 
 
 Modern culture, in the name of westernization, has changed our life style 
which in turn has changed our food habits and health care. This has lead to an 
increased incidence of various disorders like diabetes, hypertension and 
hyperlipidemia. 
 Hyperlipidemia is a heterogenous group of disorders characterized by 
abnormal elevated levels of any or all lipids and/ or lipoproteins in the blood. It is also 
known as hyperlipoproteinemea and is considered as a key risk factor for cardio 
vascular disorders (CVD)
1
. 
 The causes of hyperlipidemia are mainly life style changes (poor diet, 
smoking, alcohol). The hyperlipidemia may be primary ie. Genetic (monogenic, 
polygenic) or secondary which is associated with diabetes, myxedema, nephrotic 
syndrome, chronic alcoholism, drugs (corticosteroids, oral contraceptives, β-blockers) 
etc
2
. 
  At least 3/4
th
 of India’s population has abnormal levels of cholesterol that 
increases the risk of cardio vascular diseases according to a study commissioned by 
the Indian Council of Medical Research (ICMR). Studies have shown that Indians are 
affected by heart diseases at a much younger age when compared to the people in the 
West. According to the statistics provided by the Tamilnadu government, 1/4
th
 of all 
deaths among people in the 25-69 years age groups is due to cardio vascular diseases. 
There have been data on risk factors such as obesity, diabetes, hypertension and 
lifestyle habits such as poor diet, smoking and alcohol.  
 A study conducted across 2042 people in Tamilnadu and other cities showed 
that 4/5
th
 (79%) of population in urban and rural areas had at least one abnormality in 
lipid parameters. One in ten persons (13%) had high cholesterol level and more than 
one in five (29.5%) had high levels of triglycerides. To make it worse, 72.3% had low 
levels of HDL (good cholesterol), 11.8% had high levels of LDL (bad cholesterol). 
HDL or good cholesterol is universally low across the country. The study group found 
hypercholestremia in 18.3% of Tamilnadu population
3
. 
The common treatment for hyperlipidemia is prescription of statins, bile acid 
sequestrants, fibric acid derivatives and nicotinic acid. Adverse effects associated with 
these drugs are headache, nausea, bowel upset, rashes, sleep disturbance, abnormal 
liver function, myositis, hyperuricemia, rise in serum transaminase, muscle tenderness 
and rise in Creatine Phosphokinase levels
2
.  
 
Traditional treatment 
 Indigenous systems of medicine like Siddha, Ayurveda and Unani mainly use 
medicinal plants for treatment of various ailments of human beings and animals. With 
the development of these systems, herbal plants are being sought after, both by 
clinicians and patients in search for new cure of diseases. Herbal medicine is a form 
of complementary and alternative medicine and is becoming increasingly popular in 
both developing and developed countries
4
.  
 WHO has described traditional medicine as one of the surest means to achieve 
total health care coverage of the world’s population. In pursuance of its goal of 
providing accessible and culturally acceptable health care for the global population, 
WHO has encouraged the rational use of traditional plant based medicines by member 
states and has developed technical guidelines for the assessment of herbal 
medicines
5,6
. 
Herbal drugs have been used throughout the world and have raised greater 
attention in recent times because of their diverse nature of curing diseases, safety and 
high levels of tolerance compared to the conventional medicines. Moreover the herbs 
with natural combinations of constituents as a whole, are naturally occurring remedies 
which have proved to be more effective and safer than conventional medicines
7
. 
 Herbs that are used as anti hyperlipidemic agents are Azima tetracantha, 
Cinnamomum tamala, Commiphora mukul, Curcuma longa, Gymnema sylvestre, 
Moringa olifera, Prunus persica, Sapindus emarginatus, Solanum melongena, 
Terminalia arjuna, Terminalia palida, Terminalia paniculata
8
.  
 Solanum virginianum Linn., (commonly known as Solanum xanthocarpum) 
belonging to the Solanaceae family, well known as kantangatiri in Tamil, is an annual 
herbaceous plant mainly growing in India. It is used as a traditional healer of many 
ailments and has its own importance in Ayurveda to treat fever, cough, asthma, 
lumbago, piles, urinary diseases, heart diseases and for reducing of fat
9
. It is reported 
to be non-toxic and safe for human use
10
. All parts of the plant have been found to be 
noteworthy. 
The fruits are used as antidiabetic and anthelmintic, the root is used as an 
expectorant and is useful in asthma, cough and helps to maintain body temperature. 
The entire plant is used to treat throat infection and other inflammatory problems. 
 The present work proposes to evaluate the antihyperlipidemic activity of the 
fruits of Solanum virginianum Linn., after a thorough literature review. 
 The process of drug discovery is very complex and requires interdisciplinary 
efforts to design effective and commercially feasible drugs. Earlier, drug discovery 
was a trial and error process. The process of drug development has evolved with time. 
New understanding of the quantitative relationship between structure and biological 
activity ushered the beginning of computer-aided drug design. With the help of 
computers, a new era has begun in drug discovery. The development cost and time is 
expected to be cut by almost a third by the use of Computer Aided Drug Design
11
. 
Isolation of active constituents and synthesizing it to target the receptors is a 
tedious process. The alternative is to make it possible using in-silico studies. There 
are various softwares like Dock, Auto dock, Argus lab, Glide, Gold, Maestro etc. and 
various supporting softwares like Chemdraw, Chemsketch, Python, Molgrow etc. 
available which aid the drug discovery process and make it less tedious
12
. 
 Docking is a search database of molecular structures and retrieves all 
molecules that can interact with the molecule of interest. It attempts to find the best 
matching between two molecules. Docking is important to find inhibitors for specific 
target proteins and to design new drugs. It is acquiring importance as the number of 
protein structure increases and the efficiency increases accordingly. 
 Some of the successful outcomes of docking studies are the discovery of 
Amprenavir (Agenerase) for HIV protease inhibition by GSK and Vertex, Nelfinavir 
(Viracept) for HIV by Pfizer and Zanamivir (Relenza) for influenza neuraminidase 
inhibitor by GSK
13
.  
 
 
 
This study also attempts to evaluate in silico antihyperlipidemic activity, 
mechanism of action, ADME properties and toxicity profiles for some of the already 
isolated selected compounds of Solanum virginianum Linn., after establishing the 
antihyperlipidemic activity of Solanum virginianum Linn., fruits on rats. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
HYPERLIPIDEMIA 
 
Dyslipidemia refers to the alteration of one or many of the lipoproteins which 
may be an elevation of triglycerides or low density lipoprotein cholesterol, or 
decrease in high-density lipoprotein cholesterol. Elevation of lipid levels alone is 
termed as Hyperlipidemia
14
. 
 
Hyperlipidemia- causes
15 
 Environmental factors 
 Genetic factors 
 Secondary causes 
Environmental factors 
Dietary factors and obesity. 
Genetic factors 
        Occur due to single gene or multiple gene defects. 
Secondary causes
16 
 Diabetes mellitus    
 Hypothyroidism    
 Lipodystrophy    
 Alcoholism     
 Use of anti-hypertensive drugs,  diuretics, Glucocorticoid, Protease 
inhibitor 
 Obstructive liver disease   
 Nephritic syndrome     
 Acute intermittent porphyria     
Pathophysiology of hyperlipidemia17, 18 
Exogenous pathway of lipids  
Fat-soluble vitamins, dietary cholesterol and fatty acids are absorbed in the 
proximal part of the small intestine. Inside the intestinal lumen, the diet TG are 
hydrolysed by lipases and are also emulsified with bile acids to form micelles. 
In the enterocyte, by the addition of a free fatty acid, the cholesterol 
esterification occurs which results in the formation of cholesteryl esters. Incorporation 
of triglycerides with fatty acids containing more than 12 carbons atoms are packed 
with apo-B48, cholesteryl esters, retinyl esters, phospholipids and cholesterol 
resulting in the formation of chylomicrons.  
The newly secreted chylomicrons are called nascent chylomicrons which are 
absorbed into the intestinal lymph and carried directly through the thoracic duct to the 
blood stream. They are transported to the peripheral tissues before entering the liver. 
In heart, skeletal muscle and adipose tissue, these nascent chylomicrons are 
attached to the lipoprotein lipase anchored by a protein called phosphatidyl inositol-
anchored protein, GPIHBP1. These reactions occur mainly on the endothelial surface 
of the capillaries. They are hydrolysed by the lipoprotein lipase and the free fatty 
acids are released. HDL transfers the apo C-II to the chylomicron that acts as a 
cofactor for lipoprotein lipase. 
The released free fatty acids are taken up by heart and skeletal muscles which 
are oxidized to generate energy. They can also be re-esterified and stored as 
triglyceride. Some of the free fatty acids released will enter into the hepatocytes by 
binding with the plasma protein like albumin.  
Due to hydrolysation of its hydrophobic core the resultant chylomicrons 
progressively decrease in size. The hydrophilic lipids like cholesterol, phospholipids 
and the protein moiety apolipoproteins on the particle surface are transferred to HDL. 
These result in the formation of a chylomicron remnant which is about half the 
diameter of nascent chylomicron.   
 The chylomicron remnants are mainly made up of cholesterol and cholesteryl 
esters. These remnants are rapidly taken up by the liver from the circulation where 
apo-E act as a ligand. 
Endogenous pathway of lipids- hepatic lipids 
     The endogenous transport of cholesterol mainly involves  
 The liver which secretes apo-B lipoproteins  
 The peripheral tissues where the triglycerides particles are 
metabolized. 
The VLDL particles resemble chylomicrons in protein composition, where the 
apo-B48 is replaced by apoB-100. They have the higher ratio of cholesterol and 
triglycerides.  
The triglycerides present in the very low density lipoprotein are derived 
mainly from the esterification of long-chain fatty acids in the liver. The process of 
combining the hepatic triglycerides with the other major components of the nascent 
VLDL particle like apoB-100, phospholipids and cholesteryl esters are acquired by 
the action of the enzyme protein called microsomal triglyceride transfer protein 
(MTP).  
In the plasma, HDL transfers the apo-E and the C series of apolipoproteins to 
the VLDL particle. In the heart, skeletal muscle and adipose tissue, the triglycerides 
of the VLDL particle are hydrolysed by the lipoprotein lipase enzyme, a process 
similar to the one occurring to the chylomicron. This results in the formation of 
VLDL remnants which are called as IDL (intermediate density lipoprotein).  
 Figure 1: Exogenous and Endogenous pathway of lipids 
 
In the plasma, HDL transfers the apo-E and the C series of apolipoproteins to 
the VLDL particle. In the heart, skeletal muscle and adipose tissue, the triglycerides 
of the VLDL particle are hydrolysed by the lipoprotein lipase enzyme, a process 
similar to the one occurring to the chylomicron. This results in the formation of 
VLDL remnants which are called as IDL (intermediate density lipoprotein).  
    IDL contains almost same amounts of triglyceride and cholesterol. 40-60% 
of IDL particle are removed by the liver through endocytosis by binding to apo-E and 
apoB-100. The remaining IDL is remodeled by hepatic lipase enzyme to form LDL.  
    In this process most of the triglycerides are hydrolysed and result in the 
formation of LDL which carries apoB-100. In most of the individuals, the 
concentration of plasma cholesterol is equivalent to the amount of cholesterol present 
in the LDL particle. In the liver, about 70% of circulating LDL cholesterol is cleared 
by LDL receptor-mediated endocytosis. 
 Table 1: Classification of plasma lipid levels
19 
 
 
 
 
Type of Cholesterol Values 
 
 
LDL Cholesterol 
 <100  mg/dL           Optimal 
 100-129 mg/dL       Near/above optimal 
 130-159  mg/dL      Borderline high 
 160-189  mg/dL      High 
 >190  mg/dL           Very high 
 
Total Cholesterol 
 
 <200   mg/dL          Desirable 
 200-239 mg/dL       Borderline high 
 > 240 mg/dL           High 
 
HDL Cholesterol 
 
 < 40  mg/dL            Low 
 40-60  mg/dL          Normal 
 >60  mg/dL             High 
 
Triglycerides 
 <150 mg/dL            Normal 
 150-199  mg/dL      Borderline high 
 200-499  mg/dL      High 
 >500  mg/dL           Very high 
 Table 2: Drugs commonly used in the treatment of hyperlipidemia
20, 21 
 
Drug (daily dose) Mechanism of action Effect on lipids (%) 
1. 1. HMG-CoA reductase 
inhibitors 
 Lovastatin (10-80 mg) 
 Simvastatin (5-40 mg) 
 Atorvastatin (10-80 mg) 
 Rosuvastatin (5-20 mg) 
   Cholesterol synthesis by 
inhibition of rate limiting 
HMG-CoA reductase. 
LDL        20-55 
 
HDL       15-30 
 
TG           10-35 
1. 2. Bile acid sequestrants 
 Cholestyramine (4-16 g) 
 Colestipol (5-30 g) 
2.  
      Bile acid absorption, 
 
      hepatic conversion of 
CH to bile acids,                 
LDL receptors on 
hepatocytes. 
LDL        15-30 
 
HDL        3-5 
TG not affected 
3. 3. Fibric acid derivatives 
 Gemfibrozil (1200 mg) 
 Bezafibrate (600 mg) 
 Fenofibrate (200 mg) 
      Activity of lipoprotein 
lipase,   release of fatty 
acids from adipose tissue 
LDL        20-55 
May    LDL      when 
TG is high 
HDL       15-30 
TG           10-35 
3. 4. Nicotinic acid (2-6 g)    Production of VLDL,  
 
    Lipolysis in adipocytes. 
LDL        15-25 
 
HDL       20-35 
 
TG           20-50 
COMPUTER AIDED DRUG DESIGN
 
Computer aided drug design uses computational chemistry to discover, 
enhance or study drugs and related biologically active molecules. The most 
fundamental goal is to predict whether a given molecule will bind to a target and if so, 
how strong the binding would be. Molecular mechanics or molecular dynamics are 
most often used to predict the conformation of the small molecule and to model 
conformational changes in the biological target that may occur when the small 
molecule binds to it. This provides semi-quantitative prediction of the binding 
affinity. Also, knowledge-based scoring function may be used to provide binding 
affinity estimates. These methods use linear regression, machine learning, neural nets 
or other statistical techniques to derive predictive binding affinity equations by fitting 
experimental affinities to computationally derived interaction energies between the 
small molecule and the target
22
. 
Rational drug design
23 
Rational drug design is the strategy of creating new molecules with a certain 
functionality, based upon the ability to predict how the structure of the molecule will 
affect its behavior through physical models. This can be done either from scratch or 
by making calculated variations on a known structure and is usually contrasted with 
direct evolution. Rational drug designing is a method of finding new medications, 
based on the biological receptors and target molecules. The objective of drug design is 
to find a chemical compound that can fit to a specific cavity on a protein target both 
geometrically and chemically. 
 
 
Types of drug design 
 Ligand based drug design 
 Structure based drug design 
Ligand based drug design 
 Ligand based drug design is an indirect approach which relies on knowledge 
of other molecules that bind to the biological target of interest. These other molecules 
may be used to derive a pharmacophore model that defines the minimum necessary 
structural characteristics a molecule must possess in order to bind to the target. In 
other words, a model of the biological target may be built based on the knowledge of 
what binds to it and this model in turn may be used to design new molecular entities 
that interact with the target. 
Structure based drug design
24 
Structure based drug design is a direct approach which relies on knowledge of 
the three dimensional structure of the biological target obtained through methods such 
as x-ray crystallography and NMR spectroscopy.  If an experimental structure of a 
target is not available, it may be possible to create a homology model of the target 
based on the experimental structure of a related protein. Using the structure of the 
biological target, candidate drugs that are predicted to bind with high affinity and 
selectivity to the target may be designed using interactive graphics. This combined 
with the intuition of a medicinal chemist helps in the suggestion of new drug 
candidates. 
 
 
Docking25, 26 
Docking simply refers to the ability to position a ligand in the active or a 
designated site of a protein and calculates the specific binding affinities. Ligand-
protein docking has evolved so remarkably during the past decade that docking single 
or multiple small molecules to a receptor site is now routinely used to identify 
ligands. Optimal docking procedures need to be fast, generate reliable ligand 
geometries, rank the ligand conformation correctly (scoring) and thereby estimate the 
binding energy. A number of studies have shown that docking algorithms are capable 
of finding ligands and binding conformations at a receptor site close to experimentally 
determined structures. These algorithms are equally applicable to the identification of 
multiple proteins to which a small molecule can bind. The application of this 
approach may facilitate the prediction of either unknown or secondary therapeutic 
target proteins are side effects and toxicity of particular drugs. In computational 
structure-based drug design, the evaluations of scoring functions are the cornerstones 
to the success of design and discovery. Many approaches have been explored to 
improve their reliability and accuracy, leading to development of three families of 
scoring functions. These are force-field-based, knowledge-based and emprical-based. 
Scoring function
 
 Scoring functions are normally parameterized (or trained) against a data set 
consisting of experimentally determined binding affinities between molecular species 
similar to the species that one wishes to predict. 
 
 
 Types 
1. Force field based - Force-field affinities are estimated by summing the 
strength of intermolecular Van der Waals and electrostatic interactions 
between all atoms of the two molecules in the complex. 
2. Emprical – It is based on counting the number of various types of 
interactions between the binding partners. Counting may be based on the 
number of ligand and receptor atoms in contact with each other or by 
calculating the change in solvent accessible surface area complex compared to 
the uncomplexed ligand and protein. These interaction terms of the function 
may include hydrophobic-hydrophobic contacts, hydrophobic-hydrophilic 
contacts, number of hydrogen bonds, number of rotatable bonds immobilized 
in complex formation. 
3. Knowledge-based (also known as statistical-potentials) – This is based on 
statistical observations of intermolecular close contacts in large 3D databases 
which are used to derive "potentials of mean force". This method is founded 
on the assumption that close intermolecular interactions between certain types 
of atoms or functional groups that occur more frequently than one would 
expect by a random distribution are likely to be energetically favourable and 
therefore contribute favourably to binding affinity. 
 
Absorption, Distribution, Metabolism and Excretion (ADME) analysis
27
 
 For a drug to be pharmacologically active and exert its action, it should 
possess favourable pharmacokinetic properties like Absorption, Distribution, 
Metabolism and Excretion. In the field of drug research and development many 
promising drugs face failures because they fail to satisfy the ADME parameters. 
 To rule out the possibility of this, many in vitro studies are frequently used to 
evaluate ADME properties. Some computational methods (in silico tools) have been 
evolved to select the most suitable drug molecules. 
 
In silico modeling serves main functions in predicting ADME properties i.e, 
 A deep rooted knowledge in understanding the relationship of ADME 
parameters and the underlying (drug likeness property) molecular structural 
features to which it depends on.  
 It enhances the interest to the area of posology where it gives information 
about the drug dosage and frequency. This in turn reflects issues on 
bioavailability, crossing various biological membranes like brain, ocular and 
dermal penetration. 
 
These are the essential factors and criteria to look in, for a drug to be 
pharmacologically active and evolve as a successful clinical candidate in the 
pharmaceutical research. 
 
Prediction of ADME related parameters 
Absorption 
 To investigate this property in silico model uses simple parameters like log D 
(diffusion coefficient) and polar surface area which are the descriptors for hydrogen 
bonding capacity and log P (partition coefficient) values. These values should fall 
under the prescribed values as per the rule of thumb which determines the extent of 
absorption. 
 
Bioavailability 
 Factors like size and shape of molecule, lipophilicity and flexibility 
determines the bioavailability. 
Blood Brain Barrier penetration 
 In order for a drug to cross the blood brain barrier (molecule targeted to brain), 
as per the rule of thumb, the molecule should have log P values closer to 2 with a 
molecular mass of <450 Da and/ or with a polar surface area (PSA) <100 Å. 
Dermal and Ocular Penetration 
 For dermal and ocular route it should satisfy the existing parameters like log P 
(partition coefficient) for aqueous solubility, molecular weight and molecular 
flexibility. 
Metabolism
28 
 Various in silico approaches exist in evaluating the metabolism namely QSAR 
and 3D QSAR. Apart from those, computational chemists have updated the structural 
details in the data bases and tools for predicting metabolism. It also reveals the 
toxicity related to the molecular fragments formed by metabolic process. 
 
Evaluation of in silico toxicity
27 
 Toxicity is one of the major criteria to be considered for a molecule to shine as 
a successful clinical candidate in the pharmaceutical research. About 20-40% of the 
promising drug candidates fail because of high toxicity. Commercial in silico tools 
estimate toxicity and provide information by the use of QSAR (parameters and 
descriptors) or scientific literature. 
 In silico approaches like OSIRIS property explorer, predict carcinogenicity, 
mutagenicity, teratogenicity, immune toxicology, irritation, sensitization etc.  
REVIEW OF LITERATURE 
Review related to Solanum virginianum Linn., 
 Thakkar Atul et al., (2014) determined the alkaloidal value in seven genera 
of Solanaceae family. They concluded that Solanum xanthocarpum and 
Nicotiana plumbaginifolia have the highest alkaloid value. High alkaloid 
values justify their wide use in traditional system of medicine
29
.  
 Gaherwal S, Shiv G et al., (2014) studied the antifungal effect of aqueous 
and hexane leaf extract of Solanum xanthocarpum (Kantkari) against A.niger 
and C.albicans. The well diffusion and growth inhibition in broth methods 
were used for evaluating antifungal activity. Results indicate that the 
aqueous extract was not effective whereas hexane extract showed maximum 
growth inhibition at 500µg/ml and minimum growth inhibition at 
100µg/ml
30
. 
 Anitha Mary Mathews et al., (2014) studied the ability of aerial parts of 
Solanum xanthocarpum to promote glucose uptake. Diabetes was induced by 
the administration of STZ. Intraperitoneal administration of nicotinamide in 
the dose of 230mg/kg prior to the administration of STZ produced partial 
destruction of β cells that resembled type 2 diabetes. Treatment with the 
ethanolic extract of aerial parts and fruit of the plant, at the dose of 
400mg/kg produced significant reduction in elevated blood glucose level, 
increase in insulin level and reduction in HbA1c, CK (Creatine Kinase) and 
LDH (Lactate Dehydrogenase) value by the 28
th
 day of STZ-induced 
diabetes
31
.  
 
 Sridevi Muruhan et al., (2013) evaluated the antioxidant potential of 
alcoholic leaf extract of Solanum surattense. They performed in vitro free 
radical scavenging assays such as hydroxyl radical, hydrogen peroxide and 
superoxide anion radical scavenging assay,  2, 2-diphenyl-1-picryl hydrazyl 
radical (DPPH) assay, total antioxidant activity and reducing ability. From 
the results they have concluded that alcoholic leaf extract of S.surattense 
effectively scavenged free radicals at different concentrations
32
. 
 Singh S P et al., (2013) evaluated the effect of Solanum xanthocarpum seed 
powder on genital organs and fertility of female albino rats. Different doses 
of suspension (50, 100 & 150mg/kg/day) were selected for performing anti 
fertility activity. The genital organ weight of albino rats was reduced 
significantly (P<0.05) after the treatment at 100 and 150mg/kg doses. The 
higher doses caused histopathological changes in the ovary and uterus 
leading to 100% control of fertility as no implants were recorded in treated 
female rats on the 10
th
 day of pregnancy
33
. 
 Dinanath D Patil (2013) studied the antioxidant activity of ethanol, 
chloroform and ethyl acetate extract of leaves and stem of Solanum 
xanthocarpum Lam., by DPPH assay using BHT (Butylated Hydroxy 
Toluene) as the standard. In DPPH scavenging assay, it was shown that the 
ethanolic extract of leaves and stem shows better antioxidant activity 
compared to other extracts
34
.  
 Shraddha K More et al., (2013) evaluated the anti-inflammatory activity of 
ethanolic extract of whole plant of Solanum xanthocarpum (SxE) at the 
maximum dose 100mg/kg p.o. That dose was not sufficient to produce the 
anti-inflammatory effect in the acute phase; however in chronic 
administration, it reduced the proliferative phase of inflammation.  The anti-
inflammatory activity after chronic administration of SxE was found to be 
insignificant, which may be due to the low levels of phytochemicals present 
in whole plant as compared to fruits alone. So they have recommended fruits 
instead of whole plant for the treatment of inflammation
35
. 
 Patel P K et al., (2013) studied the antiurolithiatic activity of methanolic 
extract of fruits of S. xanthocarpum (SXME) in rats. Urolithiasis was 
induced by the administration of ethylene-glycol.  Different doses (100, 200 
and 400mg/kg p.o.) were chosen for the study. Cystone (750mg/kg, p.o.) 
served as a standard. Administration of SXME reduces the kidney weight by 
decreasing inflammation and increasing excretion of crystalline components. 
It reduced and prevented the growth of urinary stones by diuresis, 
antioxidant activity and maintaining balance between stone promoter and 
inhibitor constituents
36
. 
 Ramesh K Gupta et al., (2011) investigated the hepatoprotective potential of 
50% ethanolic fruit extract of different doses of Solanum xanthocarpum (SXE, 
100, 200 or 400mg/kg B.W. for 14 days). Biochemical parameters were used 
for assessing hepatoprotective activity. Results demonstrated that the 
treatment with SXE significantly (P<0.05- <0.001) and dose dependently 
prevented chemically induced increase in serum levels of hepatic enzymes and 
significantly (up to P<0.001) reduced the lipid peroxidation in the liver tissue 
and restored activities of defence antioxidant enzymes GSH, SOD and catalase 
to normal levels
37
. 
 
Review related to other Solanum species 
 Kateregga J N et al., (2015) have reported the antihyperlipidemic 
potential of the ethanolic extract of Solanum melongena. Hyperlipidemia 
was induced in by feeding high fat diet for 3 weeks. The extract was then 
administered orally at different doses (250 and 500mg/kg/day BW). 
Atorvastatin (4mg/kg) and distilled water, administered orally, were used as 
positive and normal control respectively. There was a significant (P<0.05) 
increase in serum total cholesterol and triglycerides in negative control 
group. The extract, at all doses, produced significant weight reduction in all 
treatment groups when compared to the normal control group. The 
500mg/kg dose of the ethanolic extract of Solanum melongena had the 
greatest (P<0.05) antihyperlipidemic activity
38
.  
 Tamegnon Victorien Dougnon et al., (2014) have reported on the 
antihyperlipidemic potential of leaves and fruits of Solanum macrocarpon. 
Hyperlipidemia was induced by Triton X-100 at a single dose of 150mg/kg 
BW, intraperitoneally. 72 hours after induction, powder of leaves and fruits 
of Solanum macrocarpon were administered daily via oral route for 7 days 
at different doses (400 and 800mg/kg BW). The biochemical parameters 
were determined 24 hours later. Treatment with Solanum macrocarpon 
showed a reduction in all hyperlipidemia parameters like TC, TG, VLDL, 
LDL and an increase in HDL. The mean differences were all statistically 
significant (P<0.05) with the exception of LDL (P=0.157)
39
. 
 
 
Review related to models used for evaluation of antihyperlipidemic 
activity
40-42 
 Cholesterol diet induced hyperlipidemia 
 Triton X- 100 induced hyperlipidemia 
High fat diet induced hyperlipidemia is one of the most commonly used 
models for the evaluation of antihyperlipidemic activity. The antihyperlipidemic 
activity of various plants was carried out by utilizing Cholesterol diet induced 
hyperlipidemia method. Some of the plants that have been evaluated for 
antihyperlipidemic activity using Cholesterol diet induced hyperlipidemia model are 
Tinospor acordifolia
43
, Terminalia paniculata
44
, Cyclocarya paliurus
45
. 
Review of in silico work 
Molecular docking is one of the most frequently used methods in structure-
based drug design, due to its ability to predict the binding-conformation of molecule 
ligands to the appropriate target binding site. Characterization of the binding 
behaviour plays an important role in rational design of drugs as well as to elucidate 
fundamental biochemical processes. The associations between biologically relevant 
molecules such as proteins, nucleic acids, carbohydrates and lipids play a central role 
in signal transduction. Furthermore, the relative orientation of the two interacting 
partners may affect the type of signal produced (eg. agonism vs antagonism)
46
. 
There are various softwares available for docking. They are, Dock, Auto dock, 
Argus lab, Glide, Gold, Maestro, etc. Glide has been optimized for docking accuracy 
and database enrichment over a wide range of systems. In order to dock ligands in a 
reasonable time, the receptor is treated rigidly. This introduces some sensitivity to the 
particular receptor conformation used for docking. Glide softens the active site        
(via vdW scaling) in order to compensate for the lack of receptor flexibility. As long 
as there are not significant receptor changes upon binding ligands, this generally is 
sufficient for screening ligands. 
If there are induced-fit effects upon binding ligands, however, using a single 
receptor conformation may penalize classes of actives that bind well to alternative 
conformations of the receptor. In such cases, it can be useful to perform ensemble 
docking (i.e., docking to mulitple receptor conformations, with optional Glide Score 
shifts to account for receptor reorganization energy)
47
.  
Zhiyoung Zhou et al., studied the Comparative performance of several flexible 
docking programs and scoring functions: Enrichment studies for a diverse set of 
pharmaceutically relevant targets. They concluded that The Glide XP methodology is 
shown to consistently yield enrichments superior to the two alternative methods, 
while GOLD outperforms and DOCK on average. The study also shows that docking 
into multiple receptor structures can decrease the docking error in screening a diverse 
set of active compounds
48
. 
Bioinformatics tools like molecular docking experiments, which involve study 
and analysis of ligand-receptor interactions, play important role in identifying 
molecular targets for different ligands. Novel molecular targets for antihyperlipidemic 
drugs have been periodically reviewed
49
. There are various molecular targets for 
antihyperlipidemic activity. Each molecular target has been individual mechanism of 
action. Molecular targets for antihyperlipidemic activity are 
 Niemann Pick C1 like 1 protein   -   Reduces the absorption of cholesterol 
                             (NPC1L1)
50 
 ATP citrate lyase (ACL)51       -   Supply Ach-Co-A which important for  
cholesterol biosynthesis 
 C-reactive protein (CRP)52        -   Damages LDL 
 Lanosterol 14α- demethylase         -   Catalyse the cholesterol biosynthesis 
(LDM)
53 
 Squalene synthase (SqS)54        -   Key cholesterol precursor 
 Farnesoid X-receptor (FXR)55      -   Cholesterol metabolism 
The molecular target NPC1L1 was chosen for docking some of the already 
isolated compounds of Solanum virginianum Linn., NPC1L1 is a gene associated with 
NPC1 which mutation results in Niemann-Pick disease. It codes for Niemann-Pick 
C1-like protein 1, found on the gastrointestinal tract epithelial cells as well as in 
hepatocytes. Specifically, it appears to bind to a critical mediator of cholesterol 
absorption
56
.  
There are various Protein Data Banks for NPC1L1 (3QNT, 3GKH, 3GKI, 
3GKJ, 3GCW, 3GCX, 3BPS). The PDB file was selected based on its species, X-ray 
crystallography or NMR spectroscopy, resolution value, external ligand and presence 
of co-factors. 3GCX was taken for this study.  
 
 
The characteristic features for 3GCX
57
 are 
Species                 -    Homosapiens 
 Resolution            -   2.7Å 
 External ligands   -    1 
 
The docked molecules are screened in silico using Molinspiration 
Cheminformatics Software to evaluate drug likeness. Toxicity screening is done in 
silico using OSIRIS property explorer. It is web based software available on the 
Organic Chemistry Portal. Using this prediction tool, mutagenicity, tumorogenicity, 
skin irritancy and reproductive effects can be calculated. 
 
 
 
 
 
 
 
 
 
 
 
 
AIM AND OBJECTIVE 
 
The literature review indicates that Solanum species offers a good potential for 
antihyperlipidemic activity. From the literature review it is clear that no scientific 
work has so far been carried out on the antihyperlipidemic potential of the fruits of 
Solanum virginianum Linn.,  
 
The aim and objective of the present study is 
 To evaluate of in vivo antihyperlipidemic potential of ethanolic extract of 
fruits of Solanum virginianum Linn., using the Cholesterol diet induced 
hyperlipidemia model in adult Wistar rats. 
 
Since in silico studies are commonly done to investigate the ADME 
properties, toxicity parameters and mechanism of action of various potential drug 
molecules, the aim of this study is also 
 To establish the antihyperlipidemic activity, ADME properties and toxicity of 
some of the already isolated selected compounds of Solanum virginianum 
Linn., using in silico studies. 
 
 
 
 
 
 
 
 
PLANT PROFILE 
                         
                      
Figure 2: Solanum virginianum Linn., 
 
Plant introduction
58, 59, 8, 9
 
Biological name  :  Solanum virginianum Linn. 
Synonyms   : Solanum surattense, Solanum mccanni,  
Solanum xanthocarpum Schard. & Windl., 
Family   :  Solanaceae 
 
Vernacular names
58, 59 
Tamil    :  Kandangattari, udavani 
Hindi    :  Chotikateri, Rengani 
Telugu    :  Nelamulaka 
English   :  Yellow-berried night shade, Febrifuge plant 
Bengali   :  Kantikari 
Sanskrit   :  Kantakari, Nidigadhika 
 
Taxonomic classification
58, 59 
Botanical name  :  Solanum virginianum Linn. 
Kingdom   :  Plantae 
Division                         :  Magnoliophyta 
Class    :  Magnoliopsida 
Order    :  Solanales 
Family    :  Solanaceae 
Genus    :  Solanum 
Species   :  virginianum  
 
 
 
Geographical distribution
58, 59 
  It is found throughout India, Malaya, Ceylon, Southeast Asia and Polynesia. 
In India, it is mainly grown in Uttar Pradesh, Bihar, Punjab, Uttaranchal, West 
Bengal, Assam and other North-Eastern States. 
 
Morphology
60, 61 
 It is a very prickly diffuse bright green perennial herb, 2-3m high, somewhat 
woody at the base, stems are zigzag, branches are numerous, prickles are compressed, 
straight, yellow, glabrous and shining, often exceeding 1-3cm long. 
 Leaves: 5-10 leaves, ovate or elliptic, sinuate or sub pinnatified, obtuse or 
subacute, stellately hairy on both sides, armed on the mid rib and often on the nerves 
with long yellow sharp prickles, base usually rounded and unequal-sided, petioles 1.3-
2.5cm long, stellately hairy and prickly. 
 Flowers: Extra-axillary few flowered cymes sometimes reduced to a single 
flower, peduncles short, pedicels short, curved, stellately hairy. Calyx: 1.3 cm, long, 
densely hairy and prickly, tube short, globos. Corolla: 2 cm, purple, long, lobes 
deltoid, acute, hairy outside. Filaments: 1.5mm long, glabrous. Anthers: 8mm. long, 
oblong-lanceolate, opening by small pores. Ovary: ovoid, glabrous. 
 Berries: 1.3-2 cm diameter, yellow or white with green veins, surrounded by 
the enlarged calyx. Seeds: 2.5 mm diameter, glabrous. 
 
 
Parts used 
 Whole plant, root, flower, fruit. 
 
Chemical constituents
62- 66 
 Plant contains alkaloids, sterols, saponins, flavonoids and their glycosides and 
also carbohydrates, fatty acids, amino acids etc.  
Bark: caffeic acid, methyl caffeate, solasonine, solasurine. 
Root: apigenin, coumarin, esculetin, esculin, scopoletin. 
Seed: glucose, linoleic acid, lysine, leucine, solanacarpine, solanacarpigenin, 
stearic acid, α-solamargine. 
Fruit: α-solamargine, β-sitosterol, campesterol, cycloartanol, esculetin, esculin,    
lupeol, solasodine, solasonine, scopoletin, solanine, solanidine, 
stigmasterol, sitosteryl glucoside, stigmasteryl glucoside, tomatidenol. 
 
Traditional uses
67, 68, 9 
 The plant has been useful in cold, cough, fever, skin diseases, cardiac 
disorders and worm infections. 
 It is also known to improve strength and immunity.  
 It is used in the treatment of asthma and chronic respiratory disorders. 
 
 
 
 PLAN OF WORK 
 
 Collection of fruits of Solanum virginianum Linn., 
 Authentication of plant material. 
 Processing of fruits and extraction of seeds with 90% ethanol. 
 In vivo antihyperlipidemic activity – Cholesterol diet induced hyperlipidemia 
model 
 Changes in body weight 
 Biochemical parameters 
 In silico antihyperlipidemic studies on selected isolated compounds of the 
plant of Solanum virginianum Linn., 
 Toxicity studies 
 Docking 
 Drug likeness 
 
 
 
 
 
 
 
 
 
 
 
 MATERIALS AND METHODS 
I. IN VIVO STUDIES 
1. Collection and identification of plant material 
The fruits of Solanum virginianum Linn., were collected from the waste lands 
in Krishnagiri district, Tamilnadu in the month of August, 2015. The plant was 
identified and authenticated by Prof. Sasikala Ethirajulu, Botanist, Siddha Central 
Research Institute, Arumbakkam, Chennai-600106. 
 
2. Preparation of plant extract69 
Chemicals 
 Analytical grade of 90% ethanol was bought from Microfine 
Chemicals, Chennai. 
Extraction 
 The fruits were washed with tap water, shade dried at room 
temperature and then subjected to size reduction to a coarse powder by using wiley 
mill. The powdered fruit material was packed in a Soxhlet apparatus and extracted 
with 90% ethanol. The extraction was continued until the color of the solvent in the 
siphon tube became colorless. The ethanolic extract was concentrated in a rotary 
evaporator and this concentrated ethanolic extract of fruits of Solanum virginianum 
Linn., (EEFSV) was used for the in vivo studies. 
 
3. In vivo screening 
3.1 Experimental animals 
Healthy wistar rats (150-200g) were procured from Animal Experimental 
Laboratory, Madras Medical College, Chennai-03. The study was approved by 
Institutional Animal Ethics Committee which is certified by the Committee for the 
Purpose of Control and Supervision of Experiments on Animals (CPCSEA), India. 
Approval Number: 04/243/CPCSEA dated 10.08.2015 
 
3.2 Maintenance of animals
70
 
The animals were kept in clean and dry polypropylene cages with stainless 
steel top grill having facilities for pelleted food and water. The animals were 
maintained in a well ventilated animal house in 12 hours and 12 hours dark cycle at a 
temperature of 28
o
C ± 2
o
C and they were acclimatized to laboratory conditions for 10 
days prior to the commencement of the experiment. The animals were fed with 
standard pellet diet and water ad libitum. All animal experiments were performed 
according to the ethical guidelines suggested by Institutional Animal Ethics 
Committee (IAEC). Paddy husk was used as bedding material and changed twice a 
week. 
 
3.3 Acute toxicity studies
71, 9 
Acute toxicity study has been already performed on the fruits of Solanum 
virginianum Linn., Fruits of Solanum virginianum Linn., were administered orally as 
a single dose to mice at different dose levels of 250, 500, 1000 and 2000mg/kg BW. 
Animals were observed periodically for the symptoms of toxicity and death within 
24h and then daily for 14 days. Fruits of Solanum virginianum Linn., produced no 
mortality at 2000mg/kg. Hence 1/10
th
 (200mg/kg) and 1/5
th 
(400mg/kg) of this dose 
was chosen for the antihyperlipidemic study.  
 
3.4 Evaluation of anti hyperlipidemic activity 
The model used to evaluate the anti hyperlipidemic activity was Cholesterol 
diet induced hyperlipidemia in rats. 
Cholesterol –diet induced hyperlipidemia in rats38, 40-45 
Cholic acid and Cholesterol powder were bought from Microfine 
Chemicals, Chennai. All the chemicals used in the study were of analytical grade. 
 
 Procedure 
Hyperlipidemia was induced in rats by administration of cholesterol diet 
for 30 days. Cholesterol diet consists of Cholesterol 12%, Cholic acid 1%, Sucrose 
40% and Coconut oil 10%. All the animals were weighed and divided into five 
groups, each group containing six animals. The details of the grouping are given in 
Table 3. 
 
 
 
 
 
 
                                           Table 3: Study design 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
S. No Group 
(n=6) 
Name of the group Treatment schedule 
 
1 
 
I 
 
Normal  control 
 
Rat chow diet for 30 days. 
 
2 
 
II 
 
Hyperlipidemic  control 
 
Cholesterol diet for 30 days. 
 
3 
 
III 
 
Standard 
Cholesterol diet for 30 days 
+ 
Atorvastatin 2mg/kg p.o from 
16
th
 to 30
th
 day. 
 
4 
 
IV 
 
Low dose 
Cholesterol diet for 30 days 
+ 
EEFSV 200mg/kg p.o from 
16
th
 to 30
th
 day. 
 
5 
 
V 
 
High dose 
Cholesterol diet for 30 days 
+ 
EEFSV 400mg/kg p.o. from 
16
th
 to 30
th
 day. 
The blood samples were collected on 0, 15
th
 and 30
th
 day of the experiment 
from the retro orbital sinus using glass capillary. The blood was allowed to clot for 30 
minutes at room temperature. The clear serum was separated by centrifugation at 
2500 rpm for 10 minutes and used for the determination of biochemical parameters. 
 
 Parameters evaluated 
 Changes in body weight 
The body weight of each animal in every group were recorded on 
0, 15
th
 and 30
th
 day of study period and the changes in body weight were noted. 
 
 Biochemical analysis 
The serum was subjected to the following evaluation 
 Total Cholesterol (TC) 
 Triglycerides (TG) 
 High density lipoprotein (HDL) 
 Very Low density lipoprotein (VLDL)  
 Low density lipoprotein (LDL) 
 
 Statistical analysis 
The results of the biochemical estimations were presented as 
mean ± SD of six animals in each group. Total variations, present in a set of data were 
estimated by One Way Analysis Of Variance (ANOVA). P value of <0.05 was 
considered statistically significant. 
 
 
II. IN SILICO STUDIES 
Review of literature showed that fruits of Solanum virginianum Linn., have 
the phytochemicals like alkaloid, phenolic compounds, flavonoid, glycoalkaloid, 
sapogenin, coumarin, steroidal alkaloid, glycoside, carbohydrate, triterpenoid, 
steroids, fatty acids, amino acids, etc
60
. Alkaloid, phenolic compounds, flavonoid, 
glycoalkaloid, sapogenin, coumarin, steroidal alkaloids were taken up for in silico 
toxicity, docking and drug likeness studies. 
Isolated compounds taken for this study include 
1. α- Solamargine   - Alkaloid 
2. Tomatidenol   - Alkaloid 
3. Esculin    - Coumarin 
4. Esculetin    - Coumarin 
5. Scopoletin    - Coumarin 
6. Apigenin    - Flavonoid 
7. Carpesterol   - Glycoalkaloid 
8. Methyl caffeate   - Phenolic 
9. Caffeic acid   - Phenolic 
10. Coumarin    - Phenolic 
11. Diosgenin     - Sapogenin 
12. Solanidine     - Steroidal alkaloid 
13. Solanine     - Steroidal alkaloid  
14. Solasodine     - Steroidal alkaloid 
15. Solasonine     - Steroidal alkaloid 
 
A. In silico toxicity prediction 
 Toxicity screening is done in silico using OSIRIS property explorer. It 
is a web based software available on the Organic Chemistry Portal. Using this 
prediction tool, mutagenicity, tumorogenicity, skin irritancy and reproductive effects 
can be calculated. The prediction properties depends on a precompiled set of structure 
fragment that gives rises to toxicity alerts, if they are found in the structure currently 
drawn. These fragment lists is created by rigorously shredding all compounds in the 
data base known to be active in a certain toxicity class. During the shredding any 
molecule is first cut at every rotatable bonds leading to a set of core fragments
76
. 
OSIRIS software is used to calculate various drug relevant properties of chemical 
structures. The results are color coded. The green color represents that the compound 
is non-toxic. Yellow and red color indicates moderate and severe toxicity of the 
chemical respectively
49
. 
 
B. Docking 
In this study, Glide (Grid based Ligand Docking with Energetics) program 
was used for screening the isolated compounds. Glide automatically searches for 
favorable interactions between ligand molecule and the receptor in different 
conformations. Docking procedure using Glide includes the following steps,  
1. Protein preparation 
2. Receptor grid generation 
3. Ligand preparation 
4. Ligand docking 
5. Visualizing docking poses 
 
1. Protein preparation 
Protein data bank (PDB) file, which is the crystallized structure of the 
receptor/ protein is imported from Protein data bank with the following                 
PDB Id: 3GCX, resolution 2.7Å, preprocessed involving addition of hydrogen, 
assigning bond order, finding overlaps, creating zero order bond to metals, creating 
disulfide bonds, filling missing side chains and loops using prime option. The water 
molecules, co-factors and unwanted chains were deleted. The energy minimization 
was done to make it ready for grid generation. The PDB file was selected based on its 
species, X-ray crystallography or NMR spectroscopy, resolution value, external 
ligand and presence of co-factors
72
. 
2. Receptor grid generation 
After the preparation of protein, the grid has to be generated which is the 
critical process. It includes defining the active site in the protein (receptor). The 
prepared protein file was loaded into the workspace. The active site residues were 
found and picked and the length for docking the ligand to the protein is given as 10Å. 
The grid was generated by pressing “start” in the grid generation tab. The grid output 
file obtained as zip file format was utilized for further docking process. 
3. Ligand preparation 
Ligand preparation process consists of a series that include conversions, 
applying corrections to the structures drawn, generating variations on the structure, 
eliminating unwanted structures and optimizing the structures. Variations on the 
structure can be made by addition of hydrogen atoms, removal of unwanted 
molecules, neutralizing changed groups. The structure can be optimized by generating 
ionization states, generating tautomers, filtering their structure on the basis of 
Lipinski’s rule of five. 
4. Ligand docking 
After the generation of grid, the prepared ligands were docked to see the 
interaction with the active site of the protein. There were hydrophobic, hydrophilic 
and Van der Waal’s interaction. The strength of the interaction was different ligand 
molecules. During the docking procedure, conformation of the ligand was retained 
and extra precision (xp) mode was selected. In this procedure, the following 
constraints like active site and rotatable groups have been checked
73
. 
5. Visualization of the docking poses 
Once the molecules were docked, then they were visualized for interactions, 
score and some other parameters like log P value and ionization value. There were 
interactions like hydrogen bonding, hydrophobic interaction, Van der Waal’s 
interaction between the receptor and the ligand. Based on the interaction and score 
obtained, the molecules were categorized into hit and flop.   
 
C. In silico screening of drug likeness 
  For a drug to be pharmacologically active and exert action it should posses 
pharmacokinetic properties like absorption, distribution, metabolism and excretion. 
Many drug failures occur due to unfavorable ADME properties in the field of drug 
research and development. This has to be ruled out earlier in the process of drug 
discovery. Some computational methods (in silico tools) have been evolved to 
investigate the most suitable drug molecules before synthesis. 
Lipinski’s rule of five also known as the Pfizer’s rule of five, is a rule to 
evaluate drug likeness. It is used to predict whether a molecule is likely to be orally 
bio-available or to evaluate drug likeness
74
. 
 
The designed and docked molecules are screened in silico using 
Molinspiration Cheminformatics Software to evaluate drug likeness. This tool is 
quick and easy to use. It can be accessed online for calculation of important molecular 
properties such as log P, polar surface area, number of hydrogen bond donors and 
acceptors as well as prediction of bioactivity score for the most important drug targets 
like GPCR ligands, kinase inhibitors, ion channel modulators, nuclear receptors
75
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RESULTS AND DISCUSSION 
I. In vivo anti hyperlipidemic activity 
A. Effect of ethanolic extract of fruits of Solanum virginianum Linn., on body 
weight of animals 
              The results are tabulated in Table 4. Hyperlipidemic rats showed an 
increase in body weight whereas the weight of the control rats remained the 
same. Administration of Atrovastatin and ethanolic extract of fruit of Solanum 
virginianum Linn., for 15 days significantly reduced the weight and brought 
back the BW towards normal. 
 
Table 4: Effect of Cholesterol diet on body weight and the effect of 
Atorvastatin and EEFSV on the weight of hyperlipidemic rats 
    
 
  Values are as expressed as mean ± SD (n=6) 
a- P <0.001 compared with control 
b- P<0.001 compared with disease control 
 
 
Group 
 Body Weight (g) 
Induction period Treatment period 
0 Day 15
th
 Day 30
th
 Day 
I 181.5±0.957 181.5±1.258 182.16±1.067 
II 179.83±1.343
 
200.33±0.942
a 
220.16±1.213
b 
III 180.83±1.34
 
199.83±1.863
a 
184.5±1.384
b 
IV 181.16±1.067
 
200.66±1.374
a 
186.83±1.674
b 
V 179.83±1.462
 
201.16±1.674
a 
184.66±1.247
b 
   Figure 3: Effect of EEFSV on body weight 
 
B. Biochemical analysis 
1. Effect of ethanolic extract of fruits of Solanum virginianum Linn., on 
Total Cholesterol level in hyperlipidemic rats 
               The results are tabulated in Table 5. Hyperlipidemic rats showed an 
increase in Total Cholesterol whereas the Total Cholesterol of the control rats 
remained the same. Administration of Atrovastatin and ethanolic extract of 
fruit of Solanum virginianum Linn., for 15 days significantly reduced the 
levels and brought back Total Cholesterol towards normal. 
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Table 5: Effect of Cholesterol diet on TC and the effect of Atorvastatin 
and EEFSV on TC of hyperlipidemic rats 
 
Group 
Total Cholesterol (mg/dL) 
Induction period Treatment 
period 
0 Day 15
th
 Day 30
th
 Day 
I 91.33±5.15 90±3.87 91±5.09 
II 89.33±5.79
  
170±5.80
 a 
252.83±4.37
 b 
III 87.16±6.09
 
170.5±5.64
a 
100.66±3.29
b 
IV 86.66±5.67
 
168±5.62
a 
115.33±3.63
b 
V 89.66±6.47 169.66±5.21
a 
103.83±2.26
b 
        
               Values are as expressed as mean ± SD (n=6) 
a- P<0.001 compared with control 
b- P<0.001 compared with disease control 
 
 
 
Figure 4: Effect of EEFSV on Total Cholesterol 
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2. Effect of ethanolic extract of fruits of Solanum virginianum Linn., on 
Triglyceride level in hyperlipidemic rats 
               The results are tabulated in Table 6. Hyperlipidemic rats showed an 
increase in Triglycerides whereas the Triglycerides of the control rats 
remained the same. Administration of Atrovastatin and ethanolic extract of 
fruit of Solanum virginianum Linn., for 15 days significantly reduced the 
levels and brought back Triglycerides towards normal. 
 
Table 6: Effect of Cholesterol diet on TG and the effect of Atorvastatin 
and EEFSV on TG of hyperlipidemic rats 
 
 
Group 
Triglycerides (mg/dL) 
Induction period Treatment period 
0 Day 15
th
 Day 30
th 
Day 
I 69±4.50 68.66±3.94 68.5±3.59 
II 70±3.05
 
150.66±4.74
a
 211.13±7.01
b 
III 69.83±2.54
 
149.66±6.15
a 
74.66±2.92
b 
IV 67.66±5.52
 
148.66±5.59
a 
96.66±3.72
b 
V 69.33±4.81
 
149.83±5.11
a 
84±2.23
b 
 
                  Values are as expressed as mean ± SD (n=6) 
a- P<0.001 compared with control 
                                           b-    P<0.001 compared with disease control 
 Figure 5: Effect of EEFSV on Triglycerides 
 
 
 
3. Effect of ethanolic extract of fruits of Solanum virginianum Linn., on 
HDL level in hyperlipidemic rats 
               The results are tabulated in Table 7. Hyperlipidemic rats showed 
decrease in HDL whereas the HDL of the control rats remained the same. 
Administration of Atrovastatin and ethanolic extract of fruit of Solanum 
virginianum Linn., for 15 days significantly increase the levels of HDL and 
brought back HDL towards normal. 
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Table 7: Effect of Cholesterol diet on HDL and the effect of Atorvastatin 
and EEFSV on HDL of hyperlipidemic rats 
 
 
Group 
HDL (mg/dL) 
Induction period Treatment 
period 
0 Day 15
th
Day 30
th
 Day 
I 25.83±2.26 25.16±2.11 25.5±1.97 
II 25.5±2.98
a 
19.5±2.81
a 
13.66±1.49
b 
III 25±1.91
b 
19.16±1.77
a 
26.16±1.95
b 
IV 25±3.26
b 
19.83±1.77
a 
22±1.29
b 
V 24.33±3.09
b 
19±2.01
a 
25.83±1.34
b 
 
                Values are as expressed as mean ± SD (n=6) 
a- P<0.001 compared with control 
                                           b-    P<0.001 compared with disease control 
 
 
                    Figure 6: Effect of EEFSV on HDL 
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4. Effect of ethanolic extract of fruits of Solanum virginianum Linn., on 
VLDL level in hyperlipidemic rats 
               The results are tabulated in Table 8. Hyperlipidemic rats showed an 
increase in VLDL whereas the VLDL of the control rats remained the same. 
Administration of Atrovastatin and ethanolic extract of fruit of Solanum 
virginianum Linn., for 15 days significantly reduced the levels and brought 
back VLDL towards normal. 
 
 
Table 8: Effect of Cholesterol diet on VLDL and the effect of Atorvastatin 
and EEFSV on VLDL of hyperlipidemic rats 
 
 
Group 
VLDL (mg/dL) 
Induction period Treatment 
period 
0 Day 15
th 
Day 30
th
 Day 
I 13.8±0.90 13.73±0.78 13.7±0.71 
II 14±0.61
 
30.13±0.94
a 
42.26±1.40
b 
III 13.96±0.50 29.93±1.23
a 
14.9±0.58
b 
IV 11.21±4.50
 
29.73±1.19
a 
19.33±0.74
b 
V 13.86±0.96
 
29.96±1.02
a 
16.8±0.44
b 
                
                 Values are as expressed as mean ± SD (n=6) 
a- P<0.001 compared with control 
                                          b-    P<0.001 compared with disease control 
 Figure 7: Effect of EEFSV on VLDL 
 
 
 
 
5. Effect of ethanolic extract of fruits of Solanum virginianum Linn., on LDL 
level in hyperlipidemic rats 
               The results are tabulated in Table 9. Hyperlipidemic rats showed an 
increase in LDL whereas the LDL of the control rats remained the same. 
Administration of Atrovastatin and ethanolic extract of fruit of Solanum 
virginianum Linn., for 15 days significantly reduced the levels and brought 
back LDL towards normal. 
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Table 9: Effect of Cholesterol diet on LDL and the effect of Atorvastatin 
and EEFSV on LDL of hyperlipidemic rats 
 
Group 
LDL (mg/dL) 
Induction period Treatment period 
0 Day 15
th 
Day 30
th 
Day 
I 53.6±5.89 51.1±5.05 51.5±6.80 
II 49.5±7.58
a 
120.36±7.51
a 
196.9±4.67
a 
III 48.2±7.08
b
 125.9±8.92
b 
59.56±5.42
b 
IV 48.11±7.76
b 
118.43±6.20
b 
74±4.25
b 
V 51.46±8.50
b
 120.7±5.89
b 
61.2±3.39
b 
 
                   Values are as expressed as mean ± SD (n=6) 
a- P<0.001 compared with control 
b- P<0.001 compared with disease control 
 
 
 
Figure 8: Effect of EEFSV on LDL 
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II. In silico studies 
A. Toxicity studies 
Toxicity is one of the major criteria to be considered for a molecule to 
shine as a successful clinical candidate in the pharmaceutical research. So the 
toxicity studies of some of the already isolated molecules of Solanum virginianum 
Linn., were performed. Toxicity was predicted by the OSIRIS Property Explorer, 
the online software of Thomas Sander, Acetelion Pharmaceuticals Ltd., 
Gewerbestrasse 16 and 4123 Allschwil, Switzerland. Prediction results were 
valued and color coded. Properties with high risks like mutagenicity, reproductive 
effect, tumorigenicity and skin irritantcy are shown in red color whereas a green 
and orange color indicates non- toxic behavior of the drug.  Toxicity parameters 
are tabulated in Table 10 and Figure 9. 
Table 10: Prediction of toxicity 
S. 
No 
Molecules Mutageni 
city 
Tumerogeni 
city 
Irritant Reproductive 
effect 
1 Apigenin - - - + 
2 Caffeic acid + + - + 
3 Carpesterol - - - - 
4 Coumarin + + - + 
5 Diosgenin - - - - 
6 Esculetin - + - - 
7 Esculin - - - - 
8 Methyl 
caffeate 
- - - - 
9 Scopletin - - - - 
10 α-Solamargine - - - - 
11 Solanidine - - - - 
12 Solanine - - - - 
13 Solasodine - - - - 
14 Solasonine - - - - 
15 Carpesterol - - - - 
-    indicates as safe; +    indicates as toxic 
Figure 9 (Part-I): Toxicity of already isolated compounds  
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Figure 9 (Part-II): Toxicity of already isolated compounds  
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 Figure 9 (Part-III): Toxicity of already isolated compounds  
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Among the 15 molecules which were subjected for evaluation 11 molecules 
were found to be non- toxic. These molecules are Carpesterol, Diosgenin, Esculin, 
Methyl caffeate, Scopletin, α-Solamargine, Solanidine, Solanine, Solasodine, 
Solasonine and Tomatidenol. 
 
 
 
B. Docking  
The same 15 compounds were docked against the target 3GCX after the active 
site on the protein was selected using Sitemap function. For perfect docking of the 
ligand into the cavity of the protein having active site, extra precision mode molecular 
docking was executed. During the docking procedure different poses of the ligand 
were generated. The ligands were docked in different poses. The best docked pose 
was selected based on the G Score and the interactions between the protein and the 
ligand. G score values are tabulated in Table 11 and Figure 10. 
Table 11: Compounds docked against 3GCX 
S. No Ligands G score D Score Lipophilic 
EvdW 
H Bond Electro 
1 Solanine -11.32 -11.32 -2.53 -7.96 -1.74 
2 Esculin -7.51 -7.51 -2.87 -3.16 -1.08 
3 Solasonine -6.66 -6.64 -3.26 -4.09 -1.05 
4 Esculetin -6.51 -6.5 -2.87 -2.47 -0.67 
5 α-Solamargine -6.24 -4.29 -1.87 -4.16 -0.75 
6 Apigenin -5.84 -5.82 -3.28 -1.47 -0.69 
7 Scopletin -5.5 -5.49 -2.83 -1.62 -0.55 
8 Caffeic acid -5.3 -5.3 -1.26 -1.66 -0.74 
9 Methyl caffeate -4.6 -4.64 -1.98 -1.53 -0.76 
10 Coumarin -4.06 -4.06 -2.71 -0.7 -0.15 
11 Solanidine -3.52 -3.52 -2.14 -0.98 -0.57 
12 Diosgenin -1.18 -1.18 -1.56 0 -0.01 
13 Solasodine -0.88 -0.86 -0.79 0 -0.35 
14 Carpesterol 0.12 0.12 -1.76 -0.44 -0.18 
15 Tomatidenol 0.79 0.81 -1.39 0 -0.24 
16 Atorvastatin -5.38 -5.38 -3.95 -2.26 -0.94 
Figure 10 (Part-I): Compounds docked against 3GCX  
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Figure 10 (Part-II): Compounds docked against 3GCX  
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Figure 10 (Part-III): Compounds docked against 3GCX  
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  It is considered that lesser the G score value greater is the binding of the 
ligand with the protein. From the G score values, it is observed that Solanine, Esculin, 
Solasonine, Esculetin, α-Solamargine, Apigenin, Scopletin and Caffeic acid showed a  
G score value ranging between -11.32 to -5.3 indicating a good score. It is also seen 
that Methyl caffeate, Coumarin, Solanidine, Diosgenin and Solasodine had a G score 
value ranging between -4.6 to – 0.88 3 indicating a moderate score as compared to 
Atorvastatin. 
 
C. Drug likeness 
All the 15 molecules were subjected to in silico evaluation using 
Molinspiration Cheminformatics Software to evaluate drug likeness. It can be 
accessed online for calculation of important molecular properties such as partition co- 
efficient, binding with human serum albumin, percentage human oral absorption, 
number of hydrogen bond donors and acceptors for the most important drug targets 
like GPCR ligands, kinase inhibitors, ion channel modulators and nuclear receptors. 
Drug likeness parameters are tabulated in Table 12.   
Table 12: Prediction of drug likeness 
 
 
 
S.No Molecule QPlogPo/W QPlogkhsa % oral human 
absorption 
Rule of 
five 
1 Carpesterol 8.44 2.305 100 2 
2 Solasodine 5.83 1.304 100 1 
3 Apigenin 1.92 0.05 75.23 0 
4 Caffeic acid 0.558 -0.798 54.28 0 
5 Coumarin 1.39 -0.554 94.30 0 
6 Diosgenin 6.124 1.642 100 1 
7 Esculetin 0.118 -0.593 69.66 0 
8 Esculin -1.596 -1.012 39.72 0 
9 Methyl caffeate 1.008 -0.407 75.97 0 
10 Scopletin 0.968 -0.492 85.73 0 
11 Solanidine 5.118 1.435 95.89 1 
12 α-Solamargine 0.473 -0.943 9.92 3 
13 Solanine -0.791 -1.045 0 3 
14 Solasonine -1.14 -1.046 0 3 
15 Tomatidenol 5.325 1.143 100 1 
16 Atorvastatin 6.812 1.124 70.53 2 
From the table,  
 QPlogPo/W - It is used to predict the Partition co-efficient of the 
molecules. The          values are normally in the range between -2.0 to 6.5. 
 QPlogkhsa - It is used to predict the binding with human serum albumin. 
The values are normally ranges between -1.5 to 1.5.  
 Percent human oral absorption - It is used to predict the human oral 
absorption on 0 to 100% scale. Absorption values normally ranges 
between 25-80%. 
 Rule of 5 - Lipinski’s rule said that molecules should possess MW<500, 
donor HB≤5, accept HB≤10, QPlogPo/W<5. Molecules that statisfy this 
rule are considered drug-like. 
 
Results indicates that 
 All the molecules possess good partition co-efficient except Carpesterol. 
 Carpesterol and Diosgenin does not show desirable binding with human 
serum albumin whereas all other molecules have good effective binding 
with human serum albumin. 
 Absorption value less than 25% are, α-Solamargine, Solanine, Solasonine 
and more than 80% are Carpesterol, Diosgenin, Solasodine,  Coumarin, 
Scopletin, Solanidine. 
 Apigenin, Caffeic acid, Esculetin, Esculin, Methyl caffeate, Scopletin, 
Coumarin have the value as 0; Solasodine, Diosgenin, Solanidine, 
Tomotidenol have the value as 1; Carpesterol have the value as 2; α-
Solamargine, Solanine, Solasonine have the value as 3. 
 
Among 15 compounds, Carpesterol, Solasodine, Apigenin, Caffeic 
acid, Coumarin, Diosgenin, Esculetin, Esculin, Methyl caffeate, Scopletin, 
Solanidine were seen to possess drug likeness.  
 
Based on the in silico studies the molecules Diosgenin, Esculin, 
Methyl caffeate, Scopletin, Solanidine, Solasonine were found to be safe, 
orally effective and possess good G scores. 
 
SUMMARY 
 
Herbal medicines are found to be effective in the treatment of various aliments 
but the major lacuna is lack of proper scientific validation. Hence the present study is 
aimed at investigating the selected plant Solanum virginianum Linn., for the 
hyperlipidemia. 
 The plant Solanum virginianum Linn., belong to Family Solanaceae, is 
claimed to be useful for reducing the fats but the claim has not been scientifically 
validated. 
Authentication of the plant material plays a key role in herbal medicine. The 
fruits of Solanum virginianum Linn., were collected from the waste lands in 
Krishnagiri district, Tamilnadu in the month of August, 2015 and authenticated by 
Prof. Sasikala Ethirajulu, Botanist, Siddha Central Research Institute, Arumbakkam, 
Chennai-600106. 
Antihyperlipidemic activity of the ethanolic extract of fruits of Solanum 
virginianum Linn., using the Cholesterol diet induced model of hyperlipidemia. The 
parameters evaluated were body weight changes and serum lipid profile. 
Administration of standard (Atorvastatin 2mg/kg b.w), ethanolic extract of fruits of 
Solanum virginianum Linn., at 200mg/kg and 400mg/kg significantly (P<0.001) 
reduced the body weight and normalized the serum lipid profile. This confirms the 
antihyperlipidemic activity of fruits of Solanum virginianum Linn., 
In silico studies like toxicity, docking and drug likeness were performed for 
establishing safety and identifying the mechanism of action of some of the selected 
molecules which have already been isolated from Solanum virginianum Linn., 
  Toxicity screening was done in silico using OSIRIS property explorer. 
Solanine, Esculin, Solasonine, Diosgenin, α-Solamargine, Solanidine, Tomatidenol, 
Methyl caffeate, Scopletin, Carpesterol, Solasodine were found to be non- toxic. 
  In docking studies Solanine, Esculin, Solasonine, Esculetin, α-Solamargine, 
Apigenin, Scopletin and Caffeic acid were good G score. Methyl caffeate, Coumarin, 
Solanidine, Diosgenin, Solasodine were posses moderate G score with the use of 
Glide. 
  Carpesterol, Solasodine, Apigenin, Caffeic acid, Coumarin, Diosgenin, 
Esculetin, Esculin, Methyl caffeate, Scopletin, Solanidine and Tomatidenol were 
posses more drug likeness with the use of Molinspiration Cheminformatics 
Software. 
Based on the in silico studies the molecules Diosgenin, Esculin, Methyl 
caffeate, Scopletin, Solanidine, Solasonine were found to be safe, orally effective with 
proven activity in terms of G score. 
 
 
 
 
 
 
 CONCLUSION 
 
It is thus concluded that ethanolic extract of fruits of Solanum virginianum 
Linn., have significant antihyperlipidemic activity. The presence of phytochemicals 
such as alkaloids, flavonoids, coumarins, phenolic compounds and glycosides are 
responsible for antihyperlipidemic activity.  
It is also concluded from in silico studies of already isolated compounds of 
Solanum virginianum Linn., against 3GCX confirming the activity through its G 
score. Most of the molecules are safe and orally effective. So the molecules can be 
docked with other target proteins on overall prospective on the mechanism of action 
of these isolated compounds.  
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